barinthuslogo.jpg
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
May 13, 2024 08:00 ET | Barinthus Biotherapeutics
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
May 13, 2024 07:35 ET | Reneo Pharmaceuticals, Inc.; OnKure, Inc
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
May 13, 2024 07:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
enteralogo.png
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024
May 13, 2024 07:00 ET | Entera Bio Ltd.
JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today...
Macomics.jpg
Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration
May 13, 2024 04:00 ET | Macomics Limited
Laboratory of Prof. Massimiliano Pagani at IFOM (the AIRC Institute of Molecular Oncology) and Macomics to bring together expertise on T-cell biology, ex-vivo tumoroids and macrophagesThe...
PBC BioVet
PBC BioVet: Eine neue Dimension in der tierärztlichen Versorgung
May 12, 2024 20:05 ET | PBC Biomed Ltd
SHANNON, Irland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed ist stolz darauf, sein neuestes Unternehmen, PBC BioVet, vorzustellen: eine engagierte Tochtergesellschaft, die darauf abzielt, die...
PBC BioVet
Présentation de PBC BioVet : une nouvelle frontière dans les soins de santé vétérinaires
May 12, 2024 20:05 ET | PBC Biomed Ltd
SHANNON, Irlande, 13 mai 2024 (GLOBE NEWSWIRE) -- PBC Biomed est fier de dévoiler son tout nouveau projet, PBC BioVet, une filiale entièrement dédiée aux soins vétérinaires. Fermement résolu à...
PBC BioVet
Introducing PBC BioVet: A New Frontier in Veterinary Healthcare
May 12, 2024 20:05 ET | PBC Biomed Ltd
SHANNON, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a...
enteralogo.png
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates
May 10, 2024 16:10 ET | Entera Bio Ltd.
JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today...
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market
May 10, 2024 07:55 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...